Cergentis news


Automated TLA protocol: new PerkinElmer & Cergentis application note

| |
1 min read

We are proud of our ongoing collaboration with PerkinElmer.

PerkinElmer has standardized and tested protocols automating Cergentis’ TLA protocol for targeted complete transgene and integration site sequencing in pharmaceutical cell line development and quality control on the Sciclone® G3 NGSx workstation and Zephyr® G3 NGS workstation.

Read the new appnote to discover how to increase your throughput and walkaway time, while eliminating inter-operator variability in sample preparation performance and sample tracking errors.

Please contact your PerkinElmer sales representative for more information.

Read Appnote

© 2012-2022 Cergentis B.V. All rights reserved.
For Research Use Only. Not for use in diagnostic procedures.